Cargando…

Ischaemic cardiac events and use of strontium ranelate in postmenopausal osteoporosis: a nested case–control study in the CPRD

SUMMARY: We explored the cardiac safety of the osteoporosis treatment strontium ranelate in the UK Clinical Practice Research Datalink. While known cardiovascular risk factors like obesity and smoking were associated with increased cardiac risk, use of strontium ranelate was not associated with any...

Descripción completa

Detalles Bibliográficos
Autores principales: Cooper, C., Fox, K. M., Borer, J. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906542/
https://www.ncbi.nlm.nih.gov/pubmed/24322476
http://dx.doi.org/10.1007/s00198-013-2582-4